JP2010540658A5 - - Google Patents

Download PDF

Info

Publication number
JP2010540658A5
JP2010540658A5 JP2010528165A JP2010528165A JP2010540658A5 JP 2010540658 A5 JP2010540658 A5 JP 2010540658A5 JP 2010528165 A JP2010528165 A JP 2010528165A JP 2010528165 A JP2010528165 A JP 2010528165A JP 2010540658 A5 JP2010540658 A5 JP 2010540658A5
Authority
JP
Japan
Prior art keywords
compound
alkyl
formula
protecting group
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010528165A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010540658A (ja
JP5735277B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/078762 external-priority patent/WO2009046308A1/en
Publication of JP2010540658A publication Critical patent/JP2010540658A/ja
Publication of JP2010540658A5 publication Critical patent/JP2010540658A5/ja
Application granted granted Critical
Publication of JP5735277B2 publication Critical patent/JP5735277B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010528165A 2007-10-03 2008-10-03 ハリコンドリンb類似体の合成のための中間体および方法 Active JP5735277B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99762507P 2007-10-03 2007-10-03
US60/997,625 2007-10-03
PCT/US2008/078762 WO2009046308A1 (en) 2007-10-03 2008-10-03 Intermediates and methods for the synthesis of halichondrin b analogs

Publications (3)

Publication Number Publication Date
JP2010540658A JP2010540658A (ja) 2010-12-24
JP2010540658A5 true JP2010540658A5 (OSRAM) 2011-12-15
JP5735277B2 JP5735277B2 (ja) 2015-06-17

Family

ID=40019255

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010528165A Active JP5735277B2 (ja) 2007-10-03 2008-10-03 ハリコンドリンb類似体の合成のための中間体および方法

Country Status (11)

Country Link
US (6) US8093410B2 (OSRAM)
EP (2) EP2578576B9 (OSRAM)
JP (1) JP5735277B2 (OSRAM)
CN (3) CN108948039B (OSRAM)
BR (1) BRPI0817909B1 (OSRAM)
CA (1) CA2701534C (OSRAM)
IL (1) IL204791A (OSRAM)
MX (1) MX2010003599A (OSRAM)
RU (1) RU2489437C2 (OSRAM)
SG (1) SG10201811715YA (OSRAM)
WO (1) WO2009046308A1 (OSRAM)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2682878B2 (ja) 1989-11-27 1997-11-26 上村工業株式会社 シールド付き電気めっき装置
DK1087960T3 (da) 1998-06-17 2011-06-14 Eisai R&D Man Co Ltd Makrocykliske analoger og fremgangsmåder til deres anvendelse og fremstilling
US7982060B2 (en) 2004-06-03 2011-07-19 Eisai R&D Management Co., Ltd. Intermediates for the preparation of analogs of Halichondrin B
WO2009046308A1 (en) 2007-10-03 2009-04-09 Eisai R & D Management Co., Ltd. Intermediates and methods for the synthesis of halichondrin b analogs
SG189739A1 (en) 2008-04-04 2013-05-31 Eisai R&D Man Co Ltd Halichondrin b analogs
DE102009012660A1 (de) * 2009-03-13 2010-09-16 H.C. Starck Clevios Gmbh Polymerbeschichtungen mit verbesserter Temperaturstabilität
MY160203A (en) 2009-03-30 2017-02-28 Eisai R&D Man Co Ltd Liposome composition
EP2528914B1 (en) 2010-01-26 2014-06-11 Eisai R&D Management Co., Ltd. Furo[3,2-b]pyrane derivatives useful in the synthesis of halichondrin b analogs
CN102225921B (zh) * 2011-04-26 2013-04-24 中国人民解放军第二军医大学 一种环戊烷聚酮类化合物simplextone A及其用途
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
EP2928464A1 (en) 2012-12-04 2015-10-14 Eisai R&D Management Co., Ltd. Use of eribulin in the treatment of breast cancer
KR102265952B1 (ko) 2013-06-26 2021-06-16 에자이 알앤드디 매니지먼트 가부시키가이샤 암 치료 병용요법으로서 에리불린 및 렌바티닙의 용도
JP6625533B2 (ja) 2013-11-04 2019-12-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体
CN105916861B (zh) 2013-12-06 2018-12-14 卫材R&D管理有限公司 可用于合成软海绵素b类似物的方法
SG11201609777SA (en) 2014-05-28 2016-12-29 Eisai R&D Man Co Ltd Use of eribulin in the treatment of cancer
EP3160970A4 (en) 2014-06-30 2017-12-27 President and Fellows of Harvard College Synthesis of halichondrin analogs and uses thereof
US10208058B2 (en) 2014-09-09 2019-02-19 Cipla Limited Process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts and intermediates thereof
CA2978226C (en) 2015-03-04 2025-02-18 Eisai R&D Management Co., Ltd. COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR/FGFR/RET TYROSINE KINASE INHIBITOR TO TREAT CANCER
EP3265122B1 (en) 2015-03-04 2022-05-04 Merck Sharp & Dohme Corp. Combination of pembrolizumab and eribulin for treating triple-negative breast cancer
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
RU2739034C2 (ru) 2015-05-07 2020-12-21 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Реакции макроциклизации и промежуточное соединение и другие фрагменты, полезные в синтезе макролидов галихондринов
CN108601760A (zh) 2016-02-12 2018-09-28 卫材R&D管理有限公司 艾日布林的合成中的中间体及相关的合成方法
SMT202100416T1 (it) 2016-03-02 2021-09-14 Eisai R&D Man Co Ltd Coniugati anticorpo-farmaco a base di eribulina e metodi di uso
JP7015237B2 (ja) 2016-04-28 2022-02-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍の成長を抑制する方法
CN114805322B (zh) * 2016-06-30 2025-05-30 卫材R&D管理有限公司 可用于合成软海绵素大环内酯类及其类似物的普林斯反应和中间体
KR20190082782A (ko) 2016-10-14 2019-07-10 머크 샤프 앤드 돔 코포레이션 요로상피암을 치료하기 위한 pd-1 길항제 및 에리불린의 조합
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
KR102634732B1 (ko) 2017-04-05 2024-02-13 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 마크로시클릭 화합물 및 그의 용도
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
EP4169924A3 (en) * 2017-07-06 2023-07-05 President And Fellows Of Harvard College Synthesis of halichondrins
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
US20190046513A1 (en) 2017-08-10 2019-02-14 Huya Bioscience International, Llc Combination therapies of hdac inhibitors and tubulin inhibitors
CN117924310A (zh) 2017-11-15 2024-04-26 哈佛大学的校长及成员们 大环化合物及其用途
US11419856B2 (en) 2017-11-20 2022-08-23 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of neoplastic diseases
CN118894868A (zh) 2018-01-03 2024-11-05 卫材R&D管理有限公司 可用于合成软海绵素大环内酯及其类似物的普林斯反应和化合物
US11447499B2 (en) 2019-06-14 2022-09-20 Rk Pharma Inc. Process for the preparation of eribulin mesylate intermediate
JP7574232B2 (ja) 2019-06-21 2024-10-28 カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ ホモプロパルギルアルコールを調製するための化学酵素的プロセス
US12036204B2 (en) 2019-07-26 2024-07-16 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
CN110981903A (zh) * 2019-11-28 2020-04-10 南京正济医药研究有限公司 一种艾日布林中间体化合物提高光学纯度的精制方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2027890C3 (de) * 1970-06-06 1979-02-01 Kali Chemie Ag 8-AIkoxy oder -Benzyloxy-3-methyl-lO- methylen-2,9-dioxatricyclo-(43,l,03,7 )-decan-4-one und 8-AIkoxy oder 8-Benzyloxy-3,10-dimethyl-2,9dioxatricyclo- (43,1,O" )-decan-4-one
SU652180A1 (ru) 1975-12-16 1979-03-15 Краснодарский политехнический институт 1(Фурил-2,)-2-(2-,, формилфурил-5,, ) этилен или его метильное производное как промежуточный продукт дл синтеза фуран-2,5-дикарбоновой кислоты и способ его получени
US4086245A (en) * 1976-12-09 1978-04-25 The Upjohn Company Antibiotics 7-O-alkylnogarols
SU722912A1 (ru) * 1978-03-06 1980-03-25 Уфимский Нефтяной Институт Способ получени 5-метил/-4оксо3,6,8-триоксабицикло/ (3,2,1)-октана
US5338865A (en) * 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) * 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
GB9206244D0 (en) * 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
TW255880B (OSRAM) 1992-09-09 1995-09-01 Hoechst Ag
AU4255697A (en) 1996-09-06 1998-03-26 Eli Lilly And Company Catalytic selective sulfonylation process
US6870058B2 (en) 1996-12-03 2005-03-22 The Trustees Of The University Of Pennsylvania Compounds which mimic the chemical and biological properties of discodermolide
DK1087960T3 (da) * 1998-06-17 2011-06-14 Eisai R&D Man Co Ltd Makrocykliske analoger og fremgangsmåder til deres anvendelse og fremstilling
US6653341B1 (en) * 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
DE10106647A1 (de) 2001-02-12 2002-08-22 Univ Hannover Ratjadon-Derivate zum Hemmen des Zellwachstums
CA2822994C (en) * 2004-06-03 2016-09-27 Eisai R&D Management Co., Ltd. Intermediates for the preparation of analogs of halichondrin b
US7982060B2 (en) 2004-06-03 2011-07-19 Eisai R&D Management Co., Ltd. Intermediates for the preparation of analogs of Halichondrin B
US20060045846A1 (en) 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
US20060154312A1 (en) 2004-12-09 2006-07-13 Sergei Agoulnik Tubulin isotype screening in cancer therapy using halichondrin B analogs
US7915457B2 (en) 2005-09-26 2011-03-29 Symrise Gmbh & Co. Kg Intramolecular Prins reaction and catalysts suitable therefor
WO2008010776A1 (en) 2006-07-21 2008-01-24 Agency For Science, Technology And Research Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection
US8119839B2 (en) 2007-07-20 2012-02-21 Yamada Apiculture Center, Inc. Carboxylic acid and antidepressant composition containing the same as active ingredient
WO2009046308A1 (en) * 2007-10-03 2009-04-09 Eisai R & D Management Co., Ltd. Intermediates and methods for the synthesis of halichondrin b analogs
BRPI0820519A2 (pt) * 2007-11-16 2017-05-23 Eisai R&D Man Co Ltd intermediário para a síntese do análogo de halicondrina b e reação de dessulfonilação usada para o intermediário
SG189739A1 (en) 2008-04-04 2013-05-31 Eisai R&D Man Co Ltd Halichondrin b analogs
JP5371091B2 (ja) 2009-01-23 2013-12-18 三菱レイヨン株式会社 モノスルホン酸エステルの製造方法
EP2528914B1 (en) * 2010-01-26 2014-06-11 Eisai R&D Management Co., Ltd. Furo[3,2-b]pyrane derivatives useful in the synthesis of halichondrin b analogs
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
US9181152B2 (en) 2011-11-30 2015-11-10 Alphora Research Inc. Process for preparation of (3R)-2,4-di-leaving group-3-methylbut-1-ene
IN2014MN02106A (OSRAM) 2012-03-30 2015-09-11 Alphora Res Inc
US9850254B2 (en) 2013-07-03 2017-12-26 Sandoz Ag Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing-SO2-(p-tolyl) groups
JP6625533B2 (ja) 2013-11-04 2019-12-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体
CN105916861B (zh) 2013-12-06 2018-12-14 卫材R&D管理有限公司 可用于合成软海绵素b类似物的方法
US10208058B2 (en) 2014-09-09 2019-02-19 Cipla Limited Process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts and intermediates thereof
RU2739034C2 (ru) 2015-05-07 2020-12-21 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Реакции макроциклизации и промежуточное соединение и другие фрагменты, полезные в синтезе макролидов галихондринов
CN108601760A (zh) 2016-02-12 2018-09-28 卫材R&D管理有限公司 艾日布林的合成中的中间体及相关的合成方法
CN114805322B (zh) 2016-06-30 2025-05-30 卫材R&D管理有限公司 可用于合成软海绵素大环内酯类及其类似物的普林斯反应和中间体
WO2018217894A1 (en) 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Fluorine-labelled halichondrin derivatives and related methods of synthesis
CN118894868A (zh) 2018-01-03 2024-11-05 卫材R&D管理有限公司 可用于合成软海绵素大环内酯及其类似物的普林斯反应和化合物

Similar Documents

Publication Publication Date Title
JP2010540658A5 (OSRAM)
RU2489437C2 (ru) Промежуточные соединения и способы синтеза аналогов галихондрина в
JP2018172424A5 (OSRAM)
TWI640500B (zh) 製備曲伏前列腺素之新穎方法
EP2521717A1 (en) Method for the preparation of rivaroxaban
CN1069028A (zh) 红豆杉醇侧链的不对称合成
JP2011526896A5 (OSRAM)
JP2021503522A5 (OSRAM)
CN1589263A (zh) 光学活性氧代庚烯酸酯的制备方法
JP6121492B2 (ja) (1s,4r)−2−オキサ−3−アザビシクロ[2.2.1]ヘプト−5−エンの製造方法
AU2010275780A1 (en) Preparation of (R)- and (S)-N-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof
JPH09263583A (ja) N−ベンジルインドールの調製法
KR20220011502A (ko) 신규한 이노토디올의 제조방법
JP2008508231A5 (OSRAM)
KR20070100717A (ko) 앤지오텐신 ⅱ 수용기 길항제의 제조를 위한 중간화합물
KR101821685B1 (ko) 베라프로스트 제조 중간체의 제조방법
JPWO2006088071A1 (ja) 抗hcv作用を有する化合物の製造方法およびその中間体
US7297807B1 (en) Intermediates for the synthesis of polypropionate antibiotics
CN101842363A (zh) 制备(6r)-3-己基-4-羟基-6-十一烷基-5,6-二氢吡喃-2-酮的方法及该方法中所用的中间体
CN101842370B (zh) 手性拆分2-取代的4-取代的1,3-氧硫杂环戊烷的方法
CN1436761A (zh) 一种烷基环己基炔类液晶及其生产方法
JP3403761B2 (ja) 3,5―ジヒドロキシ―1―オクテン―7―イン類及びその製造方法
JP2020503386A (ja) エリブリンメシル酸塩の製造中間体及びその製造方法
EP2822927A1 (en) PROCESS FOR PREPARATION OF PROSTAGLANDIN F2alpha ANALOGUES
JP5300713B2 (ja) 6−ヒドロキシエチルペナム化合物の製造方法